0001214659-21-003149.txt : 20210315
0001214659-21-003149.hdr.sgml : 20210315
20210315171035
ACCESSION NUMBER: 0001214659-21-003149
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210311
FILED AS OF DATE: 20210315
DATE AS OF CHANGE: 20210315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Taglietti Marco
CENTRAL INDEX KEY: 0001408870
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38599
FILM NUMBER: 21742377
MAIL ADDRESS:
STREET 1: C/O FOREST LABORATORIES, INC.
STREET 2: 909 THIRD AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aquestive Therapeutics, Inc.
CENTRAL INDEX KEY: 0001398733
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208623253
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30 TECHNOLOGY DRIVE
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-941-1900
MAIL ADDRESS:
STREET 1: 30 TECHNOLOGY DRIVE
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: MonoSol Rx, Inc.
DATE OF NAME CHANGE: 20070507
4
1
marketforms-51885.xml
PRIMARY DOCUMENT
X0306
4
2021-03-11
0001398733
Aquestive Therapeutics, Inc.
AQST
0001408870
Taglietti Marco
C/O AQUESTIVE THERAPEUTICS, INC.
30 TECHNOLOGY DRIVE
WARREN
NJ
07059
true
false
false
false
Non-Qualified Stock Option (right to buy)
5.30
2021-03-11
4
A
false
28500
0
A
2031-03-11
Common Stock
28500
28500
D
The option vests in three equal annual installments beginning on March 11, 2022.
/s/ Lori J. Braender, as Attorney-In-Fact
2021-03-15